115 related articles for article (PubMed ID: 19222931)
1. Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate.
Hesseling P; Molyneux E; Kamiza S; Israels T; Broadhead R
Ann Trop Paediatr; 2009 Mar; 29(1):29-34. PubMed ID: 19222931
[TBL] [Abstract][Full Text] [Related]
2. The 2000 Burkitt lymphoma trial in Malawi.
Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
[TBL] [Abstract][Full Text] [Related]
3. The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy.
Hesseling PB; Njume E; Kouya F; Katayi T; Wharin P; Tamannai M; Achu P; Kidd M; McCormick P
Pediatr Hematol Oncol; 2012 Mar; 29(2):119-29. PubMed ID: 22376015
[TBL] [Abstract][Full Text] [Related]
4. Outcome is unchanged by adding vincristine upfront to the Malawi 28-day protocol for endemic Burkitt lymphoma.
Depani S; Banda K; Bailey S; Israels T; Chagaluka G; Molyneux E
Pediatr Blood Cancer; 2015 Nov; 62(11):1929-34. PubMed ID: 26052841
[TBL] [Abstract][Full Text] [Related]
5. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
Hesseling PB; Molyneux E; Kamiza S; Broadhead R
Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
7. Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis.
Sullivan MP; Ramirez I
J Clin Oncol; 1985 May; 3(5):627-36. PubMed ID: 3839010
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
[TBL] [Abstract][Full Text] [Related]
9. Endemic Burkitt lymphoma of maxillofacial region: results of induction treatment with cyclophosphamide plus methotrexate in West Africa.
Béogo R; Nacro B; Ouédraogo D; Ouoba K
Pediatr Blood Cancer; 2011 Jul; 56(7):1068-70. PubMed ID: 21344617
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Ngoma T; Adde M; Durosinmi M; Githang'a J; Aken'Ova Y; Kaijage J; Adeodou O; Rajab J; Brown BJ; Leoncini L; Naresh K; Raphael M; Hurwitz N; Scanlan P; Rohatiner A; Venzon D; Magrath I
Br J Haematol; 2012 Sep; 158(6):749-62. PubMed ID: 22844968
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Madani A; Benhmiddoune L; Zafad S; Harif M; Quessar A; Benchekroun S
Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
[TBL] [Abstract][Full Text] [Related]
14. Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: experience of Côte d'Ivoire.
Koffi GK; Tolo A; Nanho DC; N'dathz E; Kouassi MY; N'Diaye FD; Kouakou B; Meité N; Ayemou R; Sekongo M; Kouehion P; Meité M; Tea ND; Sangaré A; Sanogo I
Int J Hematol; 2010 Jun; 91(5):838-43. PubMed ID: 20480270
[TBL] [Abstract][Full Text] [Related]
15. Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).
Murphy SB; Bowman WP; Hustu HO; Berard CW
IARC Sci Publ; 1985; (60):405-18. PubMed ID: 3905592
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience.
Muwakkit SA; Razzouk BI; Shabb NS; Hancock ML; Dabbous I; Firzli S; Abboud MR
J Pediatr Hematol Oncol; 2004 Nov; 26(11):749-53. PubMed ID: 15543011
[TBL] [Abstract][Full Text] [Related]
17. High-dose cyclophosphamide and intermediate-dose methotrexate for the treatment of far-advanced Burkitt's lymphoma.
Brecher ML; Gardner RV; Ettinger LJ; Tebbi CK; Green DM; Freeman AI
Am J Pediatr Hematol Oncol; 1985; 7(2):117-24. PubMed ID: 3842557
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure in African children with Burkitt's lymphoma: a comparison of two treatment regimens.
Olowu WA; Elusiyan JB; Badejo SA; Adenowo OA
Pediatr Blood Cancer; 2006 Apr; 46(4):446-53. PubMed ID: 16206217
[TBL] [Abstract][Full Text] [Related]
20. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]